BioLine Rx Ltd (BLRX)
0.4274
0.00 (0.00%)
USD |
NASDAQ |
Nov 04, 16:00
0.4312
0.00 (0.00%)
After-Hours: 20:00
BioLine Rx Shareholders Equity (Quarterly): 13.98M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 13.98M |
March 31, 2024 | 13.06M |
December 31, 2023 | 13.22M |
September 30, 2023 | 13.13M |
June 30, 2023 | 21.05M |
March 31, 2023 | 39.11M |
December 31, 2022 | 50.84M |
September 30, 2022 | 55.52M |
June 30, 2022 | 56.57M |
March 31, 2022 | 63.41M |
December 31, 2021 | 68.09M |
September 30, 2021 | 70.90M |
June 30, 2021 | 73.89M |
March 31, 2021 | 64.65M |
December 31, 2020 | 22.03M |
September 30, 2020 | 24.81M |
June 30, 2020 | 29.23M |
March 31, 2020 | 28.51M |
December 31, 2019 | 33.38M |
September 30, 2019 | 39.20M |
June 30, 2019 | 41.78M |
March 31, 2019 | 45.89M |
December 31, 2018 | 41.32M |
September 30, 2018 | 40.58M |
June 30, 2018 | 46.19M |
Date | Value |
---|---|
March 31, 2018 | 49.02M |
December 31, 2017 | 52.88M |
September 30, 2017 | 59.02M |
June 30, 2017 | 57.43M |
March 31, 2017 | 35.72M |
December 31, 2016 | 35.03M |
September 30, 2016 | 38.61M |
June 30, 2016 | 42.56M |
March 31, 2016 | 46.00M |
December 31, 2015 | 47.61M |
September 30, 2015 | 50.67M |
June 30, 2015 | 51.82M |
March 31, 2015 | 54.19M |
December 31, 2014 | 31.80M |
September 30, 2014 | 26.86M |
June 30, 2014 | 29.29M |
March 31, 2014 | 32.23M |
December 31, 2013 | 11.72M |
September 30, 2013 | 14.08M |
June 30, 2013 | 17.29M |
March 31, 2013 | 20.26M |
December 31, 2012 | 14.97M |
September 30, 2012 | 18.26M |
June 30, 2012 | 23.98M |
March 31, 2012 | 28.12M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
13.06M
Minimum
Mar 2024
73.89M
Maximum
Jun 2021
39.76M
Average
33.38M
Median
Dec 2019
Shareholders Equity (Quarterly) Benchmarks
Compugen Ltd | 58.34M |
Pluri Inc | 0.096M |
XTL Biopharmaceuticals Ltd | 2.705M |
Can Fite Biofarma Ltd | 6.243M |
BiomX Inc | 27.42M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 64.60M |
Total Liabilities (Quarterly) | 50.62M |
Debt to Equity Ratio | 2.106 |
Current Ratio | 1.609 |
Net Debt Paydown Yield | -8.19% |